Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230903 · ClinicalTrials.gov registry record · NA

Physical Telerehabilitation in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT03230903 is a NA study of Multiple Sclerosis that has completed, run by Columbia University. The registered enrollment target is 78 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230903, a NA study of Multiple Sclerosis, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will assess the effect of Home Automated Telemanagement (HAT) on functional outcomes, levels of disablement including impairment, activity and participation, socio-behavioral parameters, and satisfaction with medical care as described below.

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Home telerehabilitation

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2016-10
Est. Completion 2020-09
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03230903

The ClinicalTrials.gov registry entry for NCT03230903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT03230903 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03230903 about?

NCT03230903 is a clinical study titled "Physical Telerehabilitation in Multiple Sclerosis". The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will...

What is the current status of trial NCT03230903?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2016-10. Estimated completion is 2020-09.

What conditions does trial NCT03230903 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03230903?

The interventions under investigation include: Usual Care (OTHER), Home telerehabilitation (OTHER).

Who is sponsoring clinical trial NCT03230903?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03230903 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.